63 related articles for article (PubMed ID: 21163134)
1. Mechanism of multidrug resistance of human small cell lung cancer cell line H446/VP.
Wang YL; Yan YL; Zhou NJ; Han S; Zhao JX; Cao CL; Lü YH
Chin Med J (Engl); 2010 Nov; 123(22):3299-303. PubMed ID: 21163134
[TBL] [Abstract][Full Text] [Related]
2. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP].
Ji FY; Qian GS; Qian P; Chen Y; Guo RL; Li SP; Huang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):156-60. PubMed ID: 16677475
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
4. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
[TBL] [Abstract][Full Text] [Related]
5. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
[TBL] [Abstract][Full Text] [Related]
6. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
7. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line.
Fukushima T; Takemura H; Yamashita T; Ishisaka T; Inai K; Imamura S; Urasaki Y; Ueda T
Anticancer Res; 1999; 19(6B):5111-5. PubMed ID: 10697518
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and functional aspects of multidrug resistance in Ehrlich ascites tumour cells.
Nielsen DL
Dan Med Bull; 2004 Nov; 51(4):393-414. PubMed ID: 16009064
[No Abstract] [Full Text] [Related]
11. Overcoming multidrug resistance in human lung cancer with novel benzo[a]quinolizin-4-ones.
Kanintronkul Y; Worayuthakarn R; Thasana N; Winayanuwattikun P; Pattanapanyasat K; Surarit R; Ruchirawat S; Svasti J
Anticancer Res; 2011 Mar; 31(3):921-7. PubMed ID: 21498714
[TBL] [Abstract][Full Text] [Related]
12. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
Matsumoto Y; Takano H; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance related genes and p53 expression in human non small cell lung cancer.
Galimberti S; Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bevilacqua G; Petrini M
Anticancer Res; 1998; 18(4C):2973-6. PubMed ID: 9713494
[TBL] [Abstract][Full Text] [Related]
14. [Role of DNA topoisomerase II alpha in intrinsic and acquired drug resistance of liver cancer].
Li QY; Wang Y; Yin ZF; Wu FC
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):620-1. PubMed ID: 19719923
[No Abstract] [Full Text] [Related]
15. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
[TBL] [Abstract][Full Text] [Related]
16. [The correlation of cyclin A gene expression with drug resistance in adult acute leukemia patients].
Ma J; Xu S; Lai Y; Lu Y
Zhonghua Xue Ye Xue Za Zhi; 2002 May; 23(5):243-6. PubMed ID: 12133445
[TBL] [Abstract][Full Text] [Related]
17. Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer.
Li Y; Ma C; Shi X; Wen Z; Li D; Sun M; Ding H
Oncol Rep; 2014 Oct; 32(4):1703-8. PubMed ID: 25070480
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines.
Wang J; Wang H; Zhao L; Fan S; Yang Z; Gao F; Chen L; Xiao GG; Molnár J; Wang Q
Anticancer Res; 2010 Sep; 30(9):3593-8. PubMed ID: 20944142
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
[TBL] [Abstract][Full Text] [Related]
20. Bromodomain and hedgehog pathway targets in small cell lung cancer.
Kaur G; Reinhart RA; Monks A; Evans D; Morris J; Polley E; Teicher BA
Cancer Lett; 2016 Feb; 371(2):225-39. PubMed ID: 26683772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
